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Branch retinal vein occlusion
Sudden painless loss of vision is typically associated with retinal conditions. Common causes of painless loss of vision include retinal vein occlusion, retinal artery occlusion, retinal detachment, and vitreous hemorrhage.
Retinal vein occlusion can be clinically classified as branch hemi-, or central, depending on where the retinal hemorrhage is located. in central retinal vein occlusion, the hemorrhage is located in all four quadrants. in hemi-retinal vein occlusion, the hemorrhage is located in only half of the retina. in branch retinal vein occlusion, the hemorrhage is located in a specific area drained by a specific retinal venule.
Retinal vein occlusion is thought to be related to the common adventitial sheath that is shared by a retinal vein and artery. 1 in almost all (99%) patients in this condition, the artery is located anterior to the vein. 2 The high differential pressure that exists between the artery and vein is though to cause the vein to collapse as it is compressed by the artery on one side and the retina on the other. This collapse causes venous return turbulence eddies that in turn lead to formation of an intravenous thrombosis at the arterial venous crossing. 1 Although this is the typical pathogenic mechanism for formation of retinal vein occlusion, other factors, such as hypercoagulable states, diabetes mellitus, glaucoma, and prothrombotic conditions, could be implicated also. 1, 3 Patients with retinal vein occlusion have a variable prognosis for improvement in vision. 4, 5 Poor vision can be associated with macular hemorrhage, macular edema that might complicate branch retinal vein occlusion, or vitreous hemorrhage secondary to posterior segment neovascularization. 1 The Branch Retinal Vein Study, a multicentre, randomized clinical trial sponsored by the United States National institutes of Health, demonstrated that laser photocoagulation was beneficial in two situations: when the occlusion was complicated by macular edema and a patient's visual acuity was less than 6/12, 4 and when the occlusion was complicated by formation of new blood vessels in the retina. 5 More recently intravitreal injection with anti-VEGF compounds and steroids have been proven to increase the risk of significant visual improvement. 6, 7, 8 
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The patient was referred to an ophthalmologist on an urgent basis. Dilated funduscopic examination demonstrated mild hypertensive retinopathy in the contralateral eye and a branch retinal vein occlusion in the affected eye. The patient was also noted to have substantial macular edema. He was referred to a retinal specialist, and the diagnosis of branch retinal vein occlusion with macular edema was confirmed. The patient also had a systemic workup that included blood pressure measurement; a fasting blood sugar test; prothrombin time and partial thromboplastin time test; and blood test for abnormalities in proteins C and S, antithrombin iii, and a screen for a mutation in factor V.
The patient was offered intravitreal injection with an anti-VEGF compound. After a series of injections the vision had improved to 6/9. To learn more about how hypertension can present in the back of the eye, please consider taking the COPE-approved case study on Hypertensive Retinopathy online at www.optocase.com (worth two hours of COPE credit). The CAO has arranged that members can take the case for free until January 31, 2015 -use coupon code HRFREE on the Cases page (you will need to register for free first).
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